Spyre Therapeutics, Inc. - COM NEW (SYRE)

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
51.4M
Holdings value Q3 2024
$1.51B
Value change Q3 2024
+$36.8M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
117
Number of buys Q3 2024
70
Number of sells Q3 2024
-42
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 51.4M $1.51B +$36.8M $29.41 117
2024 Q2 50.4M $1.18B +$422M $23.51 106
2024 Q1 31.6M $1.2B +$173M $37.93 101
2023 Q4 28M $601M +$524M $21.52 54
2023 Q3 3.26M $39.9M +$39.9M $12.25 27